Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Xavier

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
The New England Journal of Medicine|April 5, 2016
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular DiseaseEva M Lonn, Jackie Bosch, Patricio López-Jaramillo, et al.
Diabetes, Obesity & Metabolism|June 3, 2017
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutideHertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, et al.
Circulation|January 15, 2014
Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation"Lars Wallentin, Renato D Lopes, Michael Hanna, et al.
Circulation|May 4, 2013
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillationLars Wallentin, Renato D Lopes, Michael Hanna, et al.
British Journal of Anaesthesia|January 3, 2025
Preoperative estimated glomerular filtration rate to predict cardiac events in major noncardiac surgery: a secondary analysis of two large international studiesPavel S Roshanov, Michael W Walsh, Amit X Garg, et al.
Anesthesiology|February 6, 2020
One-year Results of a Factorial Randomized Trial of Aspirin versus Placebo and Clonidine versus Placebo in Patients Having Noncardiac SurgeryDaniel I Sessler, David Conen, Kate Leslie, et al.
Circulation|September 27, 2019
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS TrialStephan Windecker, Renato D Lopes, Tyler Massaro, et al.
CJC Open|March 7, 2022
The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and ChallengesJohn Eikelboom, Sumathy Rangarajan, Sanjit S Jolly, et al.
Lancet (London, England)|June 15, 2018
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trialP J Devereaux, Emmanuelle Duceppe, Gordon Guyatt, et al.
American Journal of Hypertension|November 16, 2020
Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control StudyConor Judge, Martin J O'Donnell, Graeme J Hankey, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|April 5, 2016
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular DiseaseEva M Lonn, Jackie Bosch, Patricio López-Jaramillo, et al.
Diabetes, Obesity & Metabolism|June 3, 2017
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutideHertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, et al.
Circulation|January 15, 2014
Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation"Lars Wallentin, Renato D Lopes, Michael Hanna, et al.
Circulation|May 4, 2013
Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillationLars Wallentin, Renato D Lopes, Michael Hanna, et al.
British Journal of Anaesthesia|January 3, 2025
Preoperative estimated glomerular filtration rate to predict cardiac events in major noncardiac surgery: a secondary analysis of two large international studiesPavel S Roshanov, Michael W Walsh, Amit X Garg, et al.
Anesthesiology|February 6, 2020
One-year Results of a Factorial Randomized Trial of Aspirin versus Placebo and Clonidine versus Placebo in Patients Having Noncardiac SurgeryDaniel I Sessler, David Conen, Kate Leslie, et al.
Circulation|September 27, 2019
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS TrialStephan Windecker, Renato D Lopes, Tyler Massaro, et al.
CJC Open|March 7, 2022
The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and ChallengesJohn Eikelboom, Sumathy Rangarajan, Sanjit S Jolly, et al.
Lancet (London, England)|June 15, 2018
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trialP J Devereaux, Emmanuelle Duceppe, Gordon Guyatt, et al.
American Journal of Hypertension|November 16, 2020
Urinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control StudyConor Judge, Martin J O'Donnell, Graeme J Hankey, et al.
Pageof 16